Condition: Status Epilepticus · Sponsor: University of Virginia
The goal of this clinical trial is to determine if treatment of patients with two doses of ketamine plus levetiracetam versus levetiracetam alone leads to more effective control of status epilepticus.
This description comes directly from the study's public registry record.
Megan Wardius · 434-243-6768 · mew5j@virginia.edu
Always discuss trial participation with your own doctor first.
| Banner University Medical Center - Tucson Campus | Tucson, Arizona, United States | Recruiting |
| Ronald Reagan UCLA Medical Center | Los Angeles, California, United States | Not Yet Recruiting |
| Children's Hospital Los Angeles | Los Angeles, California, United States | Not Yet Recruiting |
| Stanford University Medical Center | Palo Alto, California, United States | Not Yet Recruiting |
| UC Davis Medical Center | Sacramento, California, United States | Recruiting |
| San Francisco General Hospital | San Francisco, California, United States | Not Yet Recruiting |
| UCSF Medical Center | San Francisco, California, United States | Not Yet Recruiting |
| Yale New Haven Hospital | New Haven, Connecticut, United States | Recruiting |
| Christiana Hospital | Newark, Delaware, United States | Not Yet Recruiting |
| Nemours Children's Hospital | Wilmington, Delaware, United States | Not Yet Recruiting |
| Children's National Medical Center | Washington D.C., District of Columbia, United States | Recruiting |
| Orlando Regional Medical Center | Orlando, Florida, United States | Not Yet Recruiting |
+ 40 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06907173